Brookfield Asset Management Inc. Zoetis Inc. Transaction History

Brookfield Asset Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	BUY	$160.94 - $186.23 $633,459 - $733,001	3,936 Added 186.81%	6,043 $1.04 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $633,459 - $733,001	3,936 Added 186.81%	6,043 $1.04 Million
Q1 2023 Sep 25, 2023	SELL	$145.48 - $175.02 $572,609 - $688,878	-3,936 Reduced 65.13%	2,107 $350,000
Q1 2023 May 15, 2023	BUY	$145.48 - $175.02 $306,526 - $368,767	2,107 New	2,107 $350,000
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $1.55 Million - $1.91 Million	10,462 New	10,462 $1.55 Million
Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $776,696 - $990,590	-4,010 Reduced 38.84%	6,314 $1.54 Million
Q1 2021 May 17, 2021	SELL	$144.0 - $169.39 $1.05 Million - $1.23 Million	-7,290 Reduced 41.39%	10,324 $1.63 Million
Q2 2020 Aug 14, 2020	BUY	$111.92 - $142.53 $1.97 Million - $2.51 Million	17,614 New	17,614 $2.41 Million

1,956

409M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $78.4B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.